CNS, Cardiometabolics A Bright Spot In Recent Chinese VC/PE Fundings

Overall Fundraising Still Muted

funding
VC and PE-backed fundings for Chinese biotechs remained lukewarm over the period from February to April. • Source: Shutterstock

More from China

More from Business